Role of tumor mutational burden (TMB) and microsatellite instability (MSI) in patients (pts) with advanced urothelial carcinoma (aUC) treated with immune checkpoint inhibitor (ICI)

被引：0

作者：

Bakaloudi, Dimitra Rafailia

Talukder, Rafee

Makrakis, Dimitrios

Diamantopoulos, Leonidas Nikolaos

Patgunarajah, Ubenthira

Thomas, Vinay Mathew

Jindal, Tanya

Brown, Jason R.

Miletic, Marija

Johnson, Jeffrey

Hui, Gavin

Buznego, Lucia Alonso

Morales-Barrera, Rafael

Castaneda, David Humberto Marmolejo

Nguyen, Charles B.

Barata, Pedro C.

Stewart, Tyler F.

Gupta, Shilpa

Grivas, Petros

Khaki, Ali Raza

机构：

[1] Univ Washington, Dept Med, Div Oncol, Seattle, WA USA

[2] Baylor Coll Med, Houston, TX USA

[3] Albert Einstein Coll Med, Jacobi Med Ctr, Dept Med, Bronx, NY USA

[4] Mayo Clin, Rochester, MN USA

[5] Cleveland Clin, Cleveland, OH USA

[6] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[7] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[8] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA

[9] Univ Hosp Ctr Sisters Mercy, Zagreb, Croatia

[10] Univ Iowa, Dept Med, Div Oncol, Iowa City, IA USA

[11] Univ Calif Los Angeles, Los Angeles, CA USA

[12] Hosp Univ Marques de Valcecilla, Santander, Spain

[13] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Barcelona, Spain

[14] Vall dHebron Univ Hosp, Barcelona, Spain

[15] Univ Michigan, Rogel Comprehens Canc Ctr, Ann Arbor, MI USA

[16] Univ Calif San Diego Hlth, La Jolla, CA USA

[17] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA

[18] Univ Washington, Div Hematol & Oncol, Seattle, WA USA

[19] Fred Hutchinson Canc Ctr, Seattle, WA USA

[20] Stanford Univ, Stanford, CA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期

关键词：

D O I：

10.1200/JCO.2024.42.4_suppl.654

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：654 / 654

页数：1

共 50 条

[31] Patients (pts) with advanced hepatocellular carcinoma (HCC) with long-term response to immune checkpoint inhibitor (ICI) therapy
Keane, F.
Cowzer, D.
Khalil, D.
Shia, J.
Do, R.
Folorunso, S.
El Dika, I.
Yaqubie, A.
Kim, T.
O'Reilly, E.
Abou-Alfa, G.
Harding, J.
[J]. ANNALS OF ONCOLOGY, 2023, 34 : S111 - S112
[32] Immunological correlates of response to immune checkpoint inhibitors (ICI) in metastatic urothelial carcinoma (mUC) patients (pts)
Tzeng, Alice
Diaz-Montero, C. Marcela
Rayman, Patricia A.
Kim, Jin Sub
Pavicic, Paul G.
Finke, James
Barata, Pedro C.
Lamenza, Marcelo
Devonshire, Sarah
Schach, Kim
Emamekhoo, Hamid
Ernstoff, Marc S.
Hoimes, Christopher J.
Rini, Brian I.
Garcia, Jorge A.
Gilligan, Timothy D.
Ornstein, Moshe Chaim
Grivas, Petros
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
[33] BODY COMPOSITION AS A PREDICTIVE AND PROGNOSTIC BIOMARKER IN ADVANCED UROTHELIAL CARCINOMA (UC) PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS (ICI)
Martini, Dylan
Shabto, Julie
Goyal, Subir
Liu, Yuan
Olsen, T. Anders
Evans, Sean
Magod, Benjamin
Ravindranathan, Deepak
Brown, Jacqueline
Yantorni, Lauren
Russler, Greta
Caulfield, Sarah
Goldman, Jamie
Nazha, Bassel
Joshi, Shreyas
Kissick, Haydn
Ogan, Kenneth
Harris, Wayne
Kucuk, Omer
Carthon, Bradley
Master, Viraj
Bilen, Mehmet
[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A27 - A29
[34] Tumor mutational burden (TMB) in real-world patients with pancreatic ductal adenocarcinoma (PDAC): Differences in genomic alterations (GA) and predictive value for immune checkpoint inhibitor (ICI) effectiveness
Mahipal, Amit
Quintanilha, Julia C. F.
Graf, Ryon
Storandt, Michael H.
Keller, Rachel B.
Li, Gerald
Ross, Jeffrey S.
Huang, Richard S. P.
Schrock, Alexa Betzig
Oxnard, Geoffrey R.
Chakrabarti, Sakti
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[35] Prevalence of high tumor mutational burden (TMB-H) and microsatellite instability-high (MSI-H) status in neuroendocrine neoplasms
Padda, Sukhmani Kaur
Aggarwal, Rahul Raj
Ashok, Arya
Mauer, Elizabeth
Shirazi, Maryam
Bergsland, Emily K.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[36] Tumor Mutational Burden as a Predictor of First-Line Immune Checkpoint Inhibitor Versus Carboplatin Benefit in Cisplatin-Unfit Patients With Urothelial Carcinoma
Graf, Ryon P.
Fisher, Virginia
Huang, Richard S. P.
Hamdani, Omar
Gjoerup, Ole V.
Stanke, Jennifer
Creeden, James
Levy, Mia A.
Oxnard, Geoffrey R.
Gupta, Shilpa
[J]. JCO PRECISION ONCOLOGY, 2022, 6
[37] Using target capture sequencing detect microsatellite instability(MSI), tumor mutational burden(TMB) and POLE/POLD1 mutations in colorectal
Wang, Jing
Liu, Dan
Wu, Huanwen M.
Yi, Yuting
Guan, Yan-Fang
Liu, Jiucheng
Yang, Ling
Yi, Xin
Xia, Xuefeng
Liang, Zhiyong
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[38] The role of previous radical local treatment (RLT) on the outcome of immune checkpoint inhibitors (ICI) in patients (pts) with metastatic urothelial carcinoma (mUC)
Morales-Barrera, Rafael
Vidal Casinello, Natalia
Domenech, Montserrat
Bonfill, Teresa
Puente, Javier
Figols, Mariona
Giner Joaquin, Julia
Gonzalez, Macarena
Lozano, Fernando
Lopez, Hector
Galante, Isabel
Mast, Richard
Serra Hernandez, Ester
Eugenia Semidey, Maria
Serrano, Cesar
Gallardo Diaz, Enrique
Suarez Rodriguez, Cristina
Maldonado, Xavier
Morote, Juan
Carles, Joan
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[39] TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor
de Kouchkovsky, Ivan
Zhang, Li
Philip, Errol J.
Wright, Francis
Kim, Daniel M.
Natesan, Divya
Kwon, Daniel
Ho, Hansen
Ho, Son
Chan, Emily
Porten, Sima P.
Wong, Anthony C.
Desai, Arpita
Huang, Franklin W.
Chou, Jonathan
Oh, David Y.
Pruthi, Raj S.
Fong, Lawrence
Small, Eric J.
Friedlander, Terence W.
Koshkin, Vadim S.
[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (05)
[40] Profiling of Tumor Mutational Burden (TMB), Microsatellite Instability (MSI), and PD1/PD-L1 Immunohistochemistry (IHC) in Gynecological Tumors
Elvin, Julia A.
Goldberg, Michael E.
Gay, Laurie M.
Liao, John
Santin, Alessandro D.
Suh, James
Vergilio, Jo-Anne
Ramkissoon, Shakti H.
Fabrizio, David
Frampton, Garrett
Stephens, Philip
Ross, Jeffrey
[J]. LABORATORY INVESTIGATION, 2017, 97 : 283A - 283A

← 1 2 3 4 5 →